Pneumococcal vaccine for adults and at risk groups (2025)

The provision of pneumococcal vaccine for adults and at risk groups (2025). The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 4,813,600 doses. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. The awarding of lots is not appropriate for this procurement due to the fact that the products are not interchangeable for the authority's use.